Story perspectives
Senate Advances Drug Patent Reforms to Lower Prices
4/6/2025
50 7
1 of 1
Story summary
- The Senate Judiciary Committee, under Senator John Cornyn's leadership, has taken a significant step by advancing six bills designed to reform drug patent laws. This move aims to boost competition and reduce soaring prices. Advocates warn that pharmaceutical companies manipulate the patent system, extending monopolies and burdening American patients with high costs.
